RO 462153

Drug Profile

RO 462153

Latest Information Update: 09 Nov 2006

Price : $50

At a glance

  • Originator Roche
  • Class Benzodiazepines
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders

Most Recent Events

  • 09 Nov 2006 Discontinued - Clinical-Phase-Unknown for Anxiety disorders in Switzerland (PO)
  • 22 Mar 2001 New profile
  • 22 Mar 2001 Investigation in Anxiety disorders in Switzerland (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top